Inactive Instrument

Analyst Reco. Renovacor, Inc.

Equities

Baird Downgrades Renovacor to Neutral From Outperform, Adjusts Price Target to $2.75 From $9	22-09-21	MT
BTIG Downgrades Renovacor to Neutral From Buy	22-09-21	MT
Ladenburg Thalmann Downgrades Renovacor to Neutral From Buy, Adjusts Price Target to $2.60 From $22	22-09-20	MT
US Futures Lower as Investors Gird for Another Fed Rate Increase	22-09-20	MT
BTIG Starts Renovacor at Buy With $8 Price Target	22-09-14	MT
Baird Initiates Renovacor at Outperform With $9 Price Target	22-09-13	MT
RENOVACOR : Ladenburg Thalmann Starts Renovacor at Buy with $22 Price Target	21-10-14	MT
RENOVACOR : Chardan Capital Initiates Renovacor at Buy Rating on Healthcare Potential, Assigns $20 Price Target	21-10-01	MT

No results for this search